Pregnancy

The safety of saquinavir (Invirase) in pregnancy is currently being investigated. Animal studies and observational studies of pregnant women taking saquinavir have shown no evidence of harmful effects to foetuses or mothers.1 2

References

  1. Zorrilla CD et al. Clinical response, safety, and tolerabiliy to saquinavir-SCG with low-dose ritonavir boosting in combination with zidovudine and lamivudine in HIV-1 infected pregnant women: preliminary results of PACTG 386. Tenth Conference on Retroviruses and Opportunistic Infections, Boston, abstract 887, 2003
  2. Vithayasai V et al. Safety and efficacy of saquinavir-soft gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission. Seventh European Conference on Clinical Aspects and Treatment of HIV Infection, Lisbon, abstract 1215, 1999
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.